Article

Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.

Department of dermatology, Ibn Sina Hospital, Mohamed V University of Rabat, Morocco.
Dermatology online journal 01/2009; 15(11):2. pp.2
Source: PubMed

ABSTRACT Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor that is responsible for several cutaneous side effects. We report a case of hand-foot syndrome associated with a papulo-pustular and seborrheic dermatitis-like eruption of the face in a 61-year-old patient treated with erlotinib for lung cancer.

0 0
 · 
0 Bookmarks
 · 
47 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

61-year-old patient
 
cutaneous side effects
 
epidermal growth factor receptor tyrosine kinase inhibitor
 
hand-foot syndrome
 
seborrheic dermatitis-like eruption
 

Sophia Benomar